Clinical Trial Update: Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India [Phase 1]

View source ↗

Summary

Phase 1 safety and acceptability study of PRO 2000 vaginal gel in HIV-uninfected women in India has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PRO 2000 vaginal gel (PRO 2000 vaginal gel)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED